Laura Orsatti

Author PubWeight™ 14.02‹?›

Top papers

Rank Title Journal Year PubWeight™‹?›
1 Mechanism of action and antiviral activity of benzimidazole-based allosteric inhibitors of the hepatitis C virus RNA-dependent RNA polymerase. J Virol 2003 2.63
2 Characterization of the inhibition of hepatitis C virus RNA replication by nonnucleosides. J Virol 2004 1.71
3 Structural and biochemical characterization of the wild type PCSK9-EGF(AB) complex and natural familial hypercholesterolemia mutants. J Biol Chem 2008 1.41
4 PP2A regulates HDAC4 nuclear import. Mol Biol Cell 2007 1.34
5 A proprotein convertase subtilisin-like/kexin type 9 (PCSK9) C-terminal domain antibody antigen-binding fragment inhibits PCSK9 internalization and restores low density lipoprotein uptake. J Biol Chem 2010 1.32
6 Hepatitis C virus NS5A is a direct substrate of casein kinase I-alpha, a cellular kinase identified by inhibitor affinity chromatography using specific NS5A hyperphosphorylation inhibitors. J Biol Chem 2006 1.30
7 Bone morphogenic protein antagonist Drm/gremlin is a novel proangiogenic factor. Blood 2006 1.04
8 Generation and selection of novel fully human monoclonal antibodies that neutralize Dickkopf-1 (DKK1) inhibitory function in vitro and increase bone mass in vivo. J Biol Chem 2010 1.04
9 Ezrin is a specific and direct target of protein tyrosine phosphatase PRL-3. Biochim Biophys Acta 2007 0.96
10 Differential screening of phage-ab libraries by oligonucleotide microarray technology. PLoS One 2008 0.84
11 An efficient and versatile synthesis of bisPNA-peptide conjugates based on chemoselective oxime formation. Bioconjug Chem 2003 0.76